Journal
CLINICAL INFECTIOUS DISEASES
Volume 37, Issue 1, Pages E8-E11Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/375689
Keywords
-
Categories
Ask authors/readers for more resources
We report 2 cases of serotonin syndrome and myelosuppression in bone marrow transplant recipients who received linezolid in combination with a selective serotonin reuptake inhibitor (SSRI). Given the risks to patients in this high-risk group, we recommend that this combination of medications be avoided if alternative antibiotic therapy is possible. If no alternative therapy is possible, prescribers should discontinue SSRI therapy and monitor these patients closely for evidence of serotonin syndrome or the development of hematological toxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available